A new study shows a patient’s overall heart disease risk assessment can better determine blood pressure treatment, as opposed to examining blood pressure levels alone.
Scientists throughout Feinberg are deeply invested in identifying health disparities — those differences in health outcomes between populations — as well as exploring novel interventions.
At Keep Your Heart Healthy events, Feinberg medical students provide cardiovascular disease risk assessment and prevention counseling to underserved communities.
Mary McDermott, MD, ’92 GME, the Jeremiah Stamler Professor of Medicine and of Preventive Medicine, has been named a Distinguished Scientist by the American Heart Association (AHA).
A Northwestern Medicine clinical trial found that a stem cell therapy did not improve walking ability in people with peripheral artery disease, although exercise did lead to significant improvements.
An online calculator showed initial success at predicting the risk of heart disease events among young, healthy adults, according to a new study in JAMA Internal Medicine.
Poor sleep may be a significant factor driving the differences in risk of cardiometabolic disease between African-Americans and European-Americans, according to a new study.
Northwestern Medicine investigators identified key areas of agreement and disagreement between cardiovascular data collected from electronic health records and data gathered in a traditional cohort study.
Northwestern will play a key role in “All of Us,” a groundbreaking national research effort to gather data from one million or more people in order to advance precision medicine.
A new strategy combining five separate tests provided a significantly better risk assessment of cardiovascular disease among adults, compared to traditional measures, according to a study published in Circulation.